Jessica Ailani, MD

Director, MedStar Georgetown Headache Center, and associate professor of neurology, MedStar Georgetown University Hospital

Articles by Jessica Ailani, MD

CGRP Monoclonal Antibodies: A Review of Trial Data

ByJessica Ailani, MD,Andrew C. Charles, MD,Christopher Gottschalk, MD,Stephanie J. Nahas, MD, MSEd,Rebecca Erwin Wells, MD, MPH

December 24th 2021

A panel of neurologists review clinical trial data on several CGRP monoclonal antibodies for migraine preventive treatment.

Preventing Migraine with CGRP Monoclonal Antibodies

ByStephanie J. Nahas, MD, MSEd,Jessica Ailani, MD,Christopher Gottschalk, MD,Rebecca Erwin Wells, MD, MPH,Andrew C. Charles, MD

December 24th 2021

Expert neurologists discuss the use of CGRP monoclonal antibodies to prevent migraines.

OnabotulinumtoxinA for Preventative Migraine Treatment

ByJessica Ailani, MD,Andrew C. Charles, MD,Christopher Gottschalk, MD,Rebecca Erwin Wells, MD, MPH,Stephanie J. Nahas, MD, MSEd

December 17th 2021

Stephanie J. Nahas, MD, MSEd, FAHS, FAAN, provides an overview of the use of onabotulinumtoxinA as a preventive migraine treatment.

Discussing Novel Agents for Preventative Migraine Therapy with Patients

ByJessica Ailani, MD,Christopher Gottschalk, MD,Andrew C. Charles, MD,Rebecca Erwin Wells, MD, MPH,Stephanie J. Nahas, MD, MSEd

December 17th 2021

A thought leader explains how she involves the patient when selecting novel agents to add to a preventive migraine treatment plan.

Preventative Migraine Therapy: Novel Agents

ByJessica Ailani, MD,Christopher Gottschalk, MD,Stephanie J. Nahas, MD, MSEd,Rebecca Erwin Wells, MD, MPH,Andrew C. Charles, MD

December 10th 2021

An introduction to the use of novel agents for preventive migraine therapy.

Behavioral Treatment Strategies for Migraine Management

ByJessica Ailani, MD,Christopher Gottschalk, MD,Andrew C. Charles, MD,Rebecca Erwin Wells, MD, MPH,Stephanie J. Nahas, MD, MSEd

December 10th 2021

An expert panel discusses migraine prevention with the use of behavioral therapies such as cognitive behavioral therapy and stress management.

Discussing Preventative Migraine Lifestyle Changes with Patients

ByJessica Ailani, MD,Christopher Gottschalk, MD,Stephanie J. Nahas, MD,Rebecca Erwin Wells, MD, MPH,Andrew C. Charles, MD

December 3rd 2021

Dr Andrew Charles shares how he eases patient anxieties over lifestyle changes for preventive migraine therapy.

Non-Drug Therapies for Migraine Prevention: Lifestyle Changes

ByJessica Ailani, MD,Christopher Gottschalk, MD,Andrew C. Charles, MD,Rebecca Erwin Wells, MD, MPH,Stephanie J. Nahas, MD

December 3rd 2021

Rebecca Erwin Wells, MD, MPH, details the effectiveness of lifestyle changes for preventative migraine treatment.

Measuring Success in Migraine Preventative Treatment

ByJessica Ailani, MD,Rebecca Erwin Wells, MD, MPH,Stephanie J. Nahas, MD, MSEd,Christopher Gottschalk, MD,Andrew C. Charles, MD

November 26th 2021

A discussion on how to measure the success of preventative migraine treatment.

Migraine Preventative Treatment and Burden of Disease

ByJessica Ailani, MD,Andrew C. Charles, MD,Stephanie J. Nahas, MD, MSEd,Christopher Gottschalk, MD,Rebecca Erwin Wells, MD, MPH

November 26th 2021

Key opinion leaders explain the burden of disease that accompanies preventative migraine treatment.

Goals of Preventative Therapy for Migraine

ByJessica Ailani, MD,Andrew C. Charles, MD,Stephanie J. Nahas, MD,Christopher Gottschalk, MD,Rebecca Erwin Wells, MD, MPH

November 19th 2021

Expert neurologists share their goals and patient considerations for preventive migraine therapy.

Migraine: A Historic Perspective on Preventative Therapy

ByJessica Ailani, MD,Stephanie J. Nahas, MD,Christopher Gottschalk, MD,Andrew C. Charles, MD,Rebecca Erwin Wells, MD, MPH

November 19th 2021

Andrew C. Charles, MD, provides a historical perspective on the agents traditionally used for preventive migraine therapy.

Jessica Ailani, MD, director, MedStar Georgetown Headache Center

What to Expect at IFN 2021: Jessica Ailani, MD

ByJessica Ailani, MD

August 12th 2021

The director of the MedStar Georgetown Headache Center discussed the upcoming International Congress on the Future of Neurology and what attendees can expect to hear from experts in migraine.

What to Expect From the 2021 American Headache Society Annual Scientific Meeting

ByJessica Ailani, MD

June 1st 2021

With the AHS 63rd Annual Scientific Meeting set to kick-off virtually on June 3, 2021, Jessica Ailani, MD, FAHS, offered her perspective on what to expect from the presentations and sessions.

Navigating Insurance and Access Issues in Migraine

ByPhilippa Cheetham, MBChB, MRCS, MD, FRCS,Jill Dehlin, RN,Jessica Ailani, MD

May 5th 2021

Current hurdles faced by neurologists when prescribing therapy to treat migraine and advice to help other healthcare professionals as well as patients navigate insurance and access issues.

Migraine Care: The Value Behind a Network of Support

ByPhilippa Cheetham, MBChB, MRCS, MD, FRCS,Jill Dehlin, RN,Jessica Ailani, MD

May 5th 2021

A patient advocate, Jill Dehlin, RN, explains why patients with migraine should connect with other patients via patient support programs and take a proactive role in managing their condition.

Treating Migraine in the Community Setting

ByPhilippa Cheetham, MBChB, MRCS, MD, FRCS,Jill Dehlin, RN,Jessica Ailani, MD

April 28th 2021

Advice to community neurologists and other care providers who may treat patients with migraine in the community setting on incorporating newer therapies, such as CGRP inhibitors, into practice, and a list of reputable resources where patients can turn for additional support.

Migraine Advocacy

ByPhilippa Cheetham, MBChB, MRCS, MD, FRCS,Jill Dehlin, RN,Jessica Ailani, MD

April 28th 2021

Jill Dehlin, RN, describes her role as an advocate in supporting others with migraine and connecting them to the support and resources needed to best manage their condition.

Assessing When to Take a Nonoral Approach to Migraine: Jessica Ailani, MD

ByJessica Ailani, MD

April 28th 2021

The director of the MedStar Georgetown Headache Center spoke to the considerations she makes in determining when patients with migraine may need a nonoral therapy to address their disease.

Providing Nonoral Migraine Care With Intranasal DHE: Jessica Ailani, MD

ByJessica Ailani, MD

April 27th 2021

The director of the MedStar Georgetown Headache Center spoke to the efficacy and application of a new formulation of the longstanding agent dihydroergotamine in the treatment of migraine.

The Safety Profiles of Therapies for Migraine

ByPhilippa Cheetham, MBChB, MRCS, MD, FRCS,Jill Dehlin, RN,Jessica Ailani, MD

April 21st 2021

The potential connection between risk of dementia in patients treated with triptans for migraine as compared to the safety profiles of newer CGRP monoclonal antibodies.

CGRP Inhibitors for Migraine

ByPhilippa Cheetham, MBChB, MRCS, MD, FRCS,Jill Dehlin, RN,Jessica Ailani, MD

April 21st 2021

Jessica Ailani, MD, of MedStar Health, describes the mechanisms of action and indications for use of currently available CGRP inhibitors for migraine.

Injectable Therapies for Migraine

ByPhilippa Cheetham, MBChB, MRCS, MD, FRCS,Jill Dehlin, RN,Jessica Ailani, MD

April 14th 2021

Jill Dehlin, RN, a patient with migraine, talks about her experience receiving a subcutaneous injectable CGRP inhibitor, and neurologist Jessica Ailani, MD, explains what she counsels her patients on when prescribing a newer injectable treatment.

Strategies for Dosing and Combining Therapy to Treat Migraine

ByPhilippa Cheetham, MBChB, MRCS, MD, FRCS,Jill Dehlin, RN,Jessica Ailani, MD

April 14th 2021

Jessica Ailani, MD, a neurologist from MedStar Health, shares insight on best practices for dosing therapies used to treat migraine and implications for combining drugs together.

Selecting Treatment to Manage Migraine

ByPhilippa Cheetham, MBChB, MRCS, MD, FRCS,Jill Dehlin, RN,Jessica Ailani, MD

April 7th 2021

Variables that neurologists and other healthcare professionals need to consider when selecting an appropriate prescription therapy for migraine, and recommendations by a patient advocate on staying adherent to therapy and predicting attacks.

Limitations of Traditional Therapies for Migraine

ByPhilippa Cheetham, MBChB, MRCS, MD, FRCS,Jill Dehlin, RN,Jessica Ailani, MD

April 7th 2021

Limitations, in terms of safety and efficacy, of older conventional therapies used to treat migraine.

Prescribing Therapy for Migraine

ByPhilippa Cheetham, MBChB, MRCS, MD, FRCS,Jill Dehlin, RN,Jessica Ailani, MD

March 31st 2021

Neurologist Jessica Ailani, MD, explains when she feels it is most appropriate to treat migraine more aggressively with prescription drugs versus with lifestyle intervention.

Diagnosing Patients With Migraine

ByPhilippa Cheetham, MBChB, MRCS, MD, FRCS,Jill Dehlin, RN,Jessica Ailani, MD

March 31st 2021

Jessica Ailani, MD, describes her approach to evaluating new patients for migraine and explains how her diagnostic work-up can impact her recommendations for treatment.